Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01408498 · ClinicalTrials.gov registry record · NA
Study on the Effects of Exogenous Testosterone on Threat Perception and Behavioral Avoidance
A NA study of Testosterone's Effects on Threat Perception/Response, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT01408498: Completed NA study of Testosterone's Effects on Threat Perception/Response, sponsored by University of Texas at Austin.
NCT01408498 is a NA study of Testosterone's Effects on Threat Perception/Response that has completed, run by University of Texas at Austin. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01408498, a NA study of Testosterone's Effects on Threat Perception/Response, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to establish a clear causal link between testosterone and threat perception and behavioral responses to threat. Namely, the study focuses whether high levels of testosterone will cause an individual to exhibit increased physiological responses to threat (e.g., increased blood pressure, heart rate, and endocrine responses) and a decreased behavioral response (e.g., ignoring the threat, avoiding the threat, and postponing dealing with the threat). The threat in this study is a social threat involving public speaking, and is an outgrowth of previous research on the avoidance of health threats.
Primary Outcome
Participants will be asked to give a public speech, but will be given the opportunity to postpone the speech to a future date. Postponement is considered an avoidance-oriented behavioral response to a perceived social threat.
Conditions Studied
Interventions
- DRUG Testosterone
Study Locations (1)
Texas
- Seay Building - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-04 |
| Phase | NA |
What the finished NCT01408498 record still lists
NCT01408498 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Testosterone's Effects on Threat Perception/Response appearing as the primary indexed condition, and to 1 intervention - of which Testosterone is the first listed.
NCT01408498 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01408498 about?
NCT01408498 is a clinical study titled "Study on the Effects of Exogenous Testosterone on Threat Perception and Behavioral Avoidance". The study aims to establish a clear causal link between testosterone and threat perception and behavioral responses to threat. Namely, the study focuses whether high levels of testosterone will cause an individual to exhibit increased physiological responses to threat (e.g., increased blood pressure...
What is the current status of trial NCT01408498?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2012-01. Estimated completion is 2012-04.
What conditions does trial NCT01408498 study?
This clinical trial studies the following conditions: Testosterone's Effects on Threat Perception/Response.
What interventions are being tested in trial NCT01408498?
The interventions under investigation include: Testosterone (DRUG).
Who is sponsoring clinical trial NCT01408498?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01408498 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01408498's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia